These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32662449)

  • 1. Driving progress in exhaled breath biomarkers: Breath Biopsy Conference 2019.
    Lawson J; Boyle B; Beauchamp J
    J Breath Res; 2020 Jul; 14(3):030202. PubMed ID: 32662449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled breath testing - A tool for the clinician and researcher.
    Davis MD; Fowler SJ; Montpetit AJ
    Paediatr Respir Rev; 2019 Feb; 29():37-41. PubMed ID: 29921519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the development of volatile exhaled breath signatures of lung cancer.
    Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
    Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breath Biomarkers in Diagnostic Applications.
    Pham YL; Beauchamp J
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled breath biopsy: a new cancer detection paradigm.
    Abderrahman B
    Future Oncol; 2019 May; 15(15):1679-1682. PubMed ID: 30977676
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of Mycobacterium tuberculosis using volatile biomarkers in culture and exhaled breath.
    Mellors TR; Nasir M; Franchina FA; Smolinska A; Blanchet L; Flynn JL; Tomko J; O'Malley M; Scanga CA; Lin PL; Wagner J; Hill JE
    J Breath Res; 2018 Oct; 13(1):016004. PubMed ID: 29910196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volatile organic compounds in cancer and exhaled breath detection technology.
    Zhou X; Qi M; Tang M; Wen S; Xue Z; Wang T
    Adv Clin Chem; 2024; 122():53-114. PubMed ID: 39111965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A breath sampling system assessing the influence of respiratory rate on exhaled breath composition.
    Lomonaco T; Salvo P; Ghimenti S; Biagini D; Bellagambi F; Fuoco R; Di Francesco F
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():7618-21. PubMed ID: 26738056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can exhaled volatile organic compounds predict asthma exacerbations in children?
    van Vliet D; Smolinska A; Jöbsis Q; Rosias P; Muris J; Dallinga J; Dompeling E; van Schooten FJ
    J Breath Res; 2017 Mar; 11(1):016016. PubMed ID: 28102830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pursuing breath research in unprecedented circumstances-report from the Breath Biopsy Conference 2020.
    Lawson J; Beauchamp J
    J Breath Res; 2021 Jun; 15(3):. PubMed ID: 34107459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva.
    Amann A; Costello Bde L; Miekisch W; Schubert J; Buszewski B; Pleil J; Ratcliffe N; Risby T
    J Breath Res; 2014 Sep; 8(3):034001. PubMed ID: 24946087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platform.
    Chou H; Godbeer L; Allsworth M; Boyle B; Ball ML
    Metabolomics; 2024 Jul; 20(4):72. PubMed ID: 38977623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breathomics from exhaled volatile organic compounds in pediatric asthma.
    Neerincx AH; Vijverberg SJH; Bos LDJ; Brinkman P; van der Schee MP; de Vries R; Sterk PJ; Maitland-van der Zee AH
    Pediatr Pulmonol; 2017 Dec; 52(12):1616-1627. PubMed ID: 29082668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled breath condensate biomarkers for lung cancer.
    Campanella A; De Summa S; Tommasi S
    J Breath Res; 2019 Aug; 13(4):044002. PubMed ID: 31282387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breathomics: Review of Sample Collection and Analysis, Data Modeling and Clinical Applications.
    Khoubnasabjafari M; Mogaddam MRA; Rahimpour E; Soleymani J; Saei AA; Jouyban A
    Crit Rev Anal Chem; 2022; 52(7):1461-1487. PubMed ID: 33691552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?
    Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D
    J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographical variation in the exhaled volatile organic compounds.
    Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H
    J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaled volatile organic compounds analysis in clinical pediatrics: a systematic review.
    Sola Martínez RA; Pastor Hernández JM; Yanes Torrado Ó; Cánovas Díaz M; de Diego Puente T; Vinaixa Crevillent M
    Pediatr Res; 2021 May; 89(6):1352-1363. PubMed ID: 32919397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.